Apollomics, Inc. (APLM) vs DarioHealth Corp. (DRIO)
A side-by-side comparison of Apollomics, Inc. and DarioHealth Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APLM
Apollomics, Inc.
$23.06HealthcareDelayed quote: Oct 6, 2026, 2:02 PM EDT
DRIO
DarioHealth Corp.
$6.00HealthcareDelayed quote: Oct 6, 2026, 2:00 PM EDT
Total return — APLM vs DRIO
growth of $100 · dividends reinvested · last 5yAPLM -97.6% (-52.8%/yr)DRIO -98.2% (-55.2%/yr)APLM compounded faster over this window
APLM DRIO
APLM vs DRIO: by the numbers
- •APLM is the larger company ($51M vs $44M market cap).
- •DRIO is profitable (322.77% net margin) while APLM runs a net loss (-128.69%).
- •APLM grew revenue faster over the past five years (35.84% vs 10.10% CAGR).
Metrics side by side
Valuation
| Metric | APLM | DRIO |
|---|---|---|
| P/E ratio | N/A | 8.70 |
| P/S ratio | N/A | 2.09 |
| P/B ratio | N/A | 0.80 |
Profitability
| Metric | APLM | DRIO |
|---|---|---|
| Gross margin | 97.00% | 56.09% |
| Operating margin | -111.45% | -163.94% |
| Net margin | -128.69% | 322.77% |
| ROE | N/A | 123.04% |
| ROIC | -2441.49% | -78.42% |
Growth (annualized)
| Metric | APLM | DRIO |
|---|---|---|
| Revenue CAGR (5Y) | 35.84% | 10.10% |
| Total return CAGR (5Y) | N/A | -52.92% |
Frequently asked
- Which has grown faster, APLM or DRIO?
- Over the past five years, APLM grew revenue faster — APLM at a 35.84% CAGR versus DRIO at 10.10%.
- Is APLM or DRIO more profitable?
- DRIO runs the higher net margin — APLM at -128.69% versus DRIO at 322.77%.
Go deeper
Dig into the metrics
DarioHealth P/E ratioApollomics ROEDarioHealth ROEApollomics operating marginDarioHealth operating marginApollomics revenue growthDarioHealth revenue growthApollomics free cash flowDarioHealth free cash flow
Apollomics & DarioHealth appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.